Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(16), 2963-2974. American Society of Clinical Oncology van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120 JOURNAL OF CLINICAL ONCOLOGY
Wijnen, N E, Koedijk, J B, Klein, K, Luesink, M, Goemans, B F, Zwaan, C M & Kaspers, G J L 2023, ' Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients : Focus on the Clinical Value of Gemtuzumab Ozogamicin ', OncoTargets and Therapy, vol. 16, pp. 297-308 . https://doi.org/10.2147/OTT.S263829